| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |